GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Profarma Distribuidora De Produtos Farmaceuticos SA (BSP:PFRM3) » Definitions » Beneish M-Score

Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Beneish M-Score : -2.55 (As of Apr. 25, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.55 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score or its related term are showing as below:

BSP:PFRM3' s Beneish M-Score Range Over the Past 10 Years
Min: -2.88   Med: -2.42   Max: -2.08
Current: -2.55

During the past 13 years, the highest Beneish M-Score of Profarma Distribuidora De Produtos Farmaceuticos was -2.08. The lowest was -2.88. And the median was -2.42.


Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Historical Data

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -2.08 -2.30 -2.39 -2.55

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.39 18.73 -2.31 -2.49 -2.55

Competitive Comparison of Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score

For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score falls into.



Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Profarma Distribuidora De Produtos Farmaceuticos for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0666+0.528 * 0.9826+0.404 * 0.8693+0.892 * 1.1082+0.115 * 0.9868
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8183+4.679 * -0.038579-0.327 * 1.0547
=-2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was R$1,327 Mil.
Revenue was 2207.034 + 2297.546 + 2133.798 + 2023.366 = R$8,662 Mil.
Gross Profit was 329.689 + 337.789 + 336.385 + 288.106 = R$1,292 Mil.
Total Current Assets was R$3,539 Mil.
Total Assets was R$4,938 Mil.
Property, Plant and Equipment(Net PPE) was R$536 Mil.
Depreciation, Depletion and Amortization(DDA) was R$149 Mil.
Selling, General, & Admin. Expense(SGA) was R$85 Mil.
Total Current Liabilities was R$2,447 Mil.
Long-Term Debt & Capital Lease Obligation was R$845 Mil.
Net Income was 28.415 + 32.161 + 14.827 + -5.006 = R$70 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = R$0 Mil.
Cash Flow from Operations was 56.748 + 454.607 + -290.13 + 39.674 = R$261 Mil.
Total Receivables was R$1,123 Mil.
Revenue was 2095.749 + 2037.748 + 1929.813 + 1752.908 = R$7,816 Mil.
Gross Profit was 289.575 + 301.445 + 318.559 + 235.935 = R$1,146 Mil.
Total Current Assets was R$2,980 Mil.
Total Assets was R$4,365 Mil.
Property, Plant and Equipment(Net PPE) was R$507 Mil.
Depreciation, Depletion and Amortization(DDA) was R$138 Mil.
Selling, General, & Admin. Expense(SGA) was R$94 Mil.
Total Current Liabilities was R$1,956 Mil.
Long-Term Debt & Capital Lease Obligation was R$802 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1326.808 / 8661.744) / (1122.539 / 7816.218)
=0.15318 / 0.143617
=1.0666

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1145.514 / 7816.218) / (1291.969 / 8661.744)
=0.146556 / 0.149158
=0.9826

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3539.367 + 535.59) / 4937.926) / (1 - (2980.433 + 506.997) / 4364.933)
=0.174763 / 0.201035
=0.8693

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8661.744 / 7816.218
=1.1082

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(138.221 / (138.221 + 506.997)) / (148.52 / (148.52 + 535.59))
=0.214224 / 0.2171
=0.9868

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(84.822 / 8661.744) / (93.548 / 7816.218)
=0.009793 / 0.011968
=0.8183

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((844.91 + 2446.645) / 4937.926) / ((802.271 + 1956.323) / 4364.933)
=0.666587 / 0.63199
=1.0547

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(70.397 - 0 - 260.899) / 4937.926
=-0.038579

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Profarma Distribuidora De Produtos Farmaceuticos has a M-score of -2.55 suggests that the company is unlikely to be a manipulator.


Profarma Distribuidora De Produtos Farmaceuticos Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Profarma Distribuidora De Produtos Farmaceuticos's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900
Profarma Distribuidora Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.

Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Headlines

No Headlines